A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy
NCT00235469
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
496
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetic Neuropathy
Interventions
DRUG:
SPM 927
Sponsor
UCB Pharma